Univest
Univest
  • Markets

MDRC Share Price rises 9.49% as MODERN DIAGNOSTIC & RESEARCH C (MDRC) trades at Rs 75

  • September 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
MDRC Share Price
MODERN DIAGNOSTIC & RESEARCH C (MDRC) share price rose to Rs 75 today, up 9.49% from the previous close. Market cap was Rs 103.43 crore.

MDRC Share Price is at Rs 75, up 9.49% today, and the company’s market capitalisation stands at Rs 103.43 crore. Modern Diagnostic & Research C is therefore among the notable movers in today’s healthcare board, even as no company-specific catalyst is established. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking MDRC Share Price Today, the move is best read through the day’s price action, the company’s valuation metrics and the healthcare peer backdrop. Univest is highlighting the stock because the rise has come with a clean intraday move from the previous close, while the latest Univest figures also place the business in a small market-cap band versus larger listed healthcare names.

For those following MDRC Share Price News, the immediate question is not only what changed in price, but what the current numbers say about valuation, returns and peer positioning. That is where MDRC Share Price analysis becomes useful: the stock is trading above the previous close, the market cap is modest, and the available fundamentals offer context for why investors may keep watching MDRC Share Price Today through the rest of the session.

Table of Contents

Toggle
  • MDRC Share Price Today: Price Action Analysis
  • MODERN DIAGNOSTIC & RESEARCH C (MDRC) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching MDRC
  • About MDRC
  • Frequently Asked Questions
    • Why is MDRC Share Price rising today?
    • What is the current MDRC Share Price?
    • What is MDRC market capitalisation?
    • What does MDRC Share Price say about valuation?
    • How strong are MDRC returns on equity and capital?
    • How does MDRC compare with healthcare peers?
    • What is the EPS and book value for MDRC Share Price?
    • Should investors track MDRC Share Price on Univest?
  • Track MDRC Share Price on Univest

MDRC Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 75
Previous Close Rs 68.5
Today's Move Rs 6.5 (+9.49%)
Open Rs 73
High Rs 75
Low Rs 70.81
Market Capitalisation Rs 103.43 crore
Market Cap Category Micro Cap

MODERN DIAGNOSTIC & RESEARCH C (MDRC) rose to Rs 75 from the previous close of Rs 68.5, a move of Rs 6.5 or 9.49%. The stock opened at Rs 73, reached a high of Rs 75, recorded a low of Rs 70.81.

MDRC Share Price moved higher by Rs 6.50 from the previous close and is trading at Rs 75 today, which reflects a 9.49% rise. The stock opened at Rs 73, touched a high of Rs 75 and a low of Rs 70.81, so the current MDRC Share Price sits at the upper end of the day’s range. That makes today’s MDRC Share Price Today move a straightforward price rise rather than a story built on any disclosed event trigger. According to latest Univest data, the market is observing a clear intraday gain, but no company-specific catalyst is established. With a market capitalisation of Rs 103.43 crore, the price action is the main verified development in MDRC Stock News and MDRC Share Price Update so far. The day’s move also places MDRC in today’s broader list of stocks rising today, while the factual evidence remains limited to price action alone. From here, the more relevant question is how MDRC Share Price fits against the company’s fundamentals.

MODERN DIAGNOSTIC & RESEARCH C (MDRC) Fundamental Analysis

Metric Value
Market Capitalisation Rs 103.43 crore
P/E Ratio 19.69x
P/B Ratio 1.8x
ROE 55.21%
ROCE 39%
EPS Rs 3.48
Book Value Per Share Rs 38.16
Dividend Yield 0%

MODERN DIAGNOSTIC & RESEARCH C (MDRC) fundamental metrics show P/E 19.69x, P/B 1.8x, ROE 55.21%, ROCE 39%. These ratios show where the company stands today and are not a call to buy or sell.

MODERN DIAGNOSTIC & RESEARCH C has a market capitalisation of Rs 103.43 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 19.69x, P/B at 1.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 55.21% and ROCE of 39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.48, book value per share of Rs 38.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 46.9x, median ROE of 13.01%, median ROCE of 15.84%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 19.69x
Benchmark Median P/E 46.9x
Benchmark Average P/E 100.02x
Benchmark P/E Range 6.8x to 1,572.9x
Company P/B Ratio 1.8x
Benchmark Median P/B 3.88x
Company ROE 55.21%
Benchmark Median ROE 13.01%
Company ROCE 39%
Benchmark Median ROCE 15.84%
Company Market Capitalisation Rs 103.43 crore
Benchmark Median Market Cap Rs 578.29 crore

MODERN DIAGNOSTIC & RESEARCH C (MDRC) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a P/E ratio of 19.69x, which is below the benchmark median of 46.9x, a difference of -58.02%. A P/E difference of this kind is a reference point rather than a recommendation.

MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a ROE of 55.21%, which is above the benchmark median of 13.01%, a difference of +324.37%. MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a ROCE of 39%, which is above the benchmark median of 15.84%, a difference of +146.21%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise Ltd. APOLLOHOSP 1,27,421.96 59.88 12.92 23.54 21.73
Max Healthcare Institute Ltd. MAXHEALTH 97,418.62 65.73 8.76 14.53 14.97
MANIPAL HEALTH ENTERPRI L MANIPALHOS 94,970.23 110.4 5.4 12.95 13.93
Aster DM Healthcare Ltd. ASTERDM 65,183.66 201.12 15.15 13.07 16.22
Fortis Healthcare Ltd. FORTIS 62,782.32 59.01 6.08 11.32 14.07

MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a P/E ratio of 19.69x compared with the displayed peer median of 65.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 55.21% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 39% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. MODERN DIAGNOSTIC & RESEARCH C (MDRC) has a market capitalisation of Rs 103.43 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching MDRC

MDRC Share Price is drawing attention for a few verified reasons:

  • MDRC Share Price is up 9.49% today and is trading at Rs 75.
  • The day’s range shows MDRC Share Price moving between Rs 70.81 and Rs 75.
  • MDRC Share Price carries a market capitalisation of Rs 103.43 crore.
  • The stock’s P/E of 19.69 and P/B of 1.8 sit below the healthcare industry benchmark.
  • ROE of 55.21% and ROCE of 39% are strong in the latest Univest figures.

About MDRC

Modern Diagnostic & Research C operates in the Healthcare sector and the Hospital & Healthcare Services industry. The current MDRC Share Price update matters because it belongs to a business being assessed on earnings, book value and returns rather than on a speculative narrative. Based on the latest Univest figures, the company is tracked through its market capitalisation, profitability ratios and price action within a healthcare framework.

For readers comparing MDRC Share Price with broader healthcare names, the business stands out because its valuation is materially lower than many listed peers while its return ratios are much higher. That combination is why MDRC Stock News and MDRC Share Price News often centre on the same set of metrics: price, valuation, earnings quality and sector context. Univest places the stock in the Hospital & Healthcare Services category, so MDRC Share Price is best understood as part of that industry’s valuation map rather than in isolation.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is MDRC Share Price rising today?

Ans. MDRC Share Price is rising today because the stock is trading at Rs 75, up 9.49% from the previous close. The price move is confirmed in Univest data; a company-specific reason has not been established.

What is the current MDRC Share Price?

Ans. MDRC Share Price is Rs 75 as of 30 September 2026 at 3:22:59 PM IST. The stock is up Rs 6.50 from the previous close of Rs 68.5, which marks a 9.49% rise.

What is MDRC market capitalisation?

Ans. MDRC market capitalisation stands at Rs 103.43 crore. That places MDRC Share Price in a relatively small market-cap bracket within the healthcare industry, especially when compared with larger listed hospital and diagnostics peers.

What does MDRC Share Price say about valuation?

Ans. MDRC Share Price is trading at a P/E ratio of 19.69 and a P/B ratio of 1.8. In the sector snapshot, both figures sit below the healthcare industry benchmark median, which gives valuation context.

How strong are MDRC returns on equity and capital?

Ans. MDRC shows ROE of 55.21% and ROCE of 39%. Those figures are above the healthcare industry benchmark medians in the latest Univest figures, which makes the return profile notable for MDRC Share Price.

How does MDRC compare with healthcare peers?

Ans. MDRC Share Price compares against peers such as Apollo Hospitals, Max Healthcare, Fortis Healthcare and others. Its valuation multiples are lower than several peers, while ROE and ROCE are higher in the reported comparison.

What is the EPS and book value for MDRC Share Price?

Ans. MDRC reports EPS of Rs 3.48 and book value of Rs 38.16 per share. These figures help frame MDRC Share Price against earnings and accounting equity, alongside the current P/E and P/B ratios.

Should investors track MDRC Share Price on Univest?

Ans. Yes, investors tracking MDRC Share Price can use Univest to follow live price, market capitalisation, valuation ratios and sector context. That helps connect the day’s price rise with the company’s listed fundamentals and peer positioning.

Track MDRC Share Price on Univest

Use MODERN DIAGNOSTIC & RESEARCH C (MDRC) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track MDRC Share Price on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels and healthcare sector context. The platform also brings together MDRC Fundamental Analysis, MDRC Stock News and MDRC Share Price Today in one place so the price action can be compared with the company’s listed peers and current metrics.

For investors following MDRC Share Price Today, Univest is useful because it keeps the latest price, valuation and industry comparison together. That makes it easier to monitor MDRC Share Price, review MDRC Stock Analysis and check how the current move fits the broader Healthcare landscape as fresh market updates appear.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply